You are now visiting tipharma.com.
On 1 January, 2016, TI Pharma and CTMM merged
to form a new organization called Lygature.
Please note that information on the tipharma.com site has not
been updated since, and is retained as an archive.
For up-to-date information, please visit lygature.org.
In November 2014, Geert Kops, Professor of Molecular Tumor Cell Biology at the University Medical...Read more
On December 15, 2014 the Boards of CTMM and TI Pharma decided to implement a new structure with...Read more
The US Patent & Trademark office (USPTO) granted a patent to the Dutch biopharmaceutical...Read more